• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-340:在人类恶性疾病中的多功能作用。

miR-340: A multifunctional role in human malignant diseases.

机构信息

Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou 325035, Zhejiang, P.R. China.

Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, P.R. China.

出版信息

Int J Biol Sci. 2021 Jan 1;17(1):236-246. doi: 10.7150/ijbs.51123. eCollection 2021.

DOI:10.7150/ijbs.51123
PMID:33390846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757049/
Abstract

MicroRNAs (miRNAs) are a class of short non-coding RNAs of approximately 22 nucleotides in length, which function by binding to the 3' UTR sequences of their target mRNAs. It has been reported that dysregulated miRNAs play pivotal roles in numerous diseases, including cancers, such as gastric, breast, colorectal, ovarian, and other cancers. Recent research efforts have been devoted to translating these basic discoveries into clinical applications that could improve the therapeutic outcome in patients with cancer. Early studies have shown that miR-340 may act either as an oncogene or a tumor suppressor by targeting genes related to proliferation, apoptosis, and metastasis, as well as those associated with diagnosis, treatment, chemoresistance, and prognosis. miR-340 has been shown to have a role in other diseases, such as autoimmune diseases, acute stroke, and alcoholic steatohepatitis. Nevertheless, the roles of miR-340 in human malignancies are still unclear, and the associated mechanisms are complex, involving a variety of signaling pathways, such as Wnt/β-catenin and the JAK-STAT pathways. Herein, we review the crucial roles of miR-340 in human cancers through the analysis of the latest research studies, with the aim of clarifying miR-340 function in malignant disease diagnosis, treatment, and prognosis, and to propose further investigations.

摘要

微小 RNA(miRNAs)是一类约 22 个核苷酸长度的短非编码 RNA,通过与靶 mRNA 的 3'UTR 序列结合发挥作用。据报道,失调的 miRNAs 在许多疾病中发挥关键作用,包括胃癌、乳腺癌、结直肠癌、卵巢癌和其他癌症等。最近的研究努力致力于将这些基础发现转化为临床应用,以改善癌症患者的治疗效果。早期研究表明,miR-340 可以通过靶向与增殖、凋亡和转移相关的基因,以及与诊断、治疗、化疗耐药性和预后相关的基因,作为癌基因或肿瘤抑制因子发挥作用。miR-340 已被证明在其他疾病中发挥作用,如自身免疫性疾病、急性中风和酒精性脂肪性肝炎。然而,miR-340 在人类恶性肿瘤中的作用仍不清楚,相关机制复杂,涉及多种信号通路,如 Wnt/β-catenin 和 JAK-STAT 通路。在此,我们通过分析最新的研究研究,综述了 miR-340 在人类癌症中的关键作用,旨在阐明 miR-340 在恶性疾病诊断、治疗和预后中的功能,并提出进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/bad4b5b3afec/ijbsv17p0236g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/f1b85083e52c/ijbsv17p0236g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/152cba291135/ijbsv17p0236g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/345ce424fcdc/ijbsv17p0236g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/651682166830/ijbsv17p0236g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/bad4b5b3afec/ijbsv17p0236g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/f1b85083e52c/ijbsv17p0236g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/152cba291135/ijbsv17p0236g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/345ce424fcdc/ijbsv17p0236g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/651682166830/ijbsv17p0236g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f1/7757049/bad4b5b3afec/ijbsv17p0236g005.jpg

相似文献

1
miR-340: A multifunctional role in human malignant diseases.miR-340:在人类恶性疾病中的多功能作用。
Int J Biol Sci. 2021 Jan 1;17(1):236-246. doi: 10.7150/ijbs.51123. eCollection 2021.
2
miR-134: A Human Cancer Suppressor?微小RNA-134:一种人类癌症抑制因子?
Mol Ther Nucleic Acids. 2017 Mar 17;6:140-149. doi: 10.1016/j.omtn.2016.11.003. Epub 2016 Dec 10.
3
MicroRNA-34a: a potential therapeutic target in human cancer.微小RNA-34a:人类癌症中的一个潜在治疗靶点。
Cell Death Dis. 2014 Jul 17;5(7):e1327. doi: 10.1038/cddis.2014.270.
4
The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers.miR-491 在人类癌症中的肿瘤抑制作用及其机制。
DNA Cell Biol. 2022 Sep;41(9):810-823. doi: 10.1089/dna.2022.0274. Epub 2022 Aug 1.
5
MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.微小RNA-218介导肿瘤发生与转移:观点与启示
Exp Cell Res. 2015 May 15;334(1):173-82. doi: 10.1016/j.yexcr.2015.03.027. Epub 2015 Apr 7.
6
A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis.微小RNA-383的简要综述:探索其在肿瘤发生中的功能见解
J Cancer. 2022 Jan 1;13(1):313-324. doi: 10.7150/jca.64846. eCollection 2022.
7
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression.MAPK/ERK 信号通路与 MicroRNAs 的相互作用:调控癌细胞代谢和肿瘤进展的关键机制。
Life Sci. 2021 Aug 1;278:119499. doi: 10.1016/j.lfs.2021.119499. Epub 2021 Apr 15.
8
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
9
MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer.miR-211 在癌症发展中起双重作用:从肿瘤抑制因子到肿瘤增强因子。
Cell Signal. 2023 Jan;101:110504. doi: 10.1016/j.cellsig.2022.110504. Epub 2022 Oct 26.
10
MicroRNA-206 in human cancer: Mechanistic and clinical perspectives.微小 RNA-206 在人类癌症中的作用机制及临床研究进展。
Cell Signal. 2023 Jan;101:110525. doi: 10.1016/j.cellsig.2022.110525. Epub 2022 Nov 16.

引用本文的文献

1
Radiation Therapy Personalization in Cancer Treatment: Strategies and Perspectives.癌症治疗中的放射治疗个体化:策略与展望
Int J Mol Sci. 2025 Jul 2;26(13):6375. doi: 10.3390/ijms26136375.
2
The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25.丝裂原活化蛋白激酶负调控因子双特异性磷酸酶2(DUSP2)受致癌性微小RNA簇miR-17-92、miR-106a-363和miR-106b-25调控。
BMC Cancer. 2025 Jun 19;25(1):1020. doi: 10.1186/s12885-025-14434-z.
3
The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy.

本文引用的文献

1
Restoration of miR-340 controls pancreatic cancer cell expression to promote macrophage phagocytosis and enhance antitumor immunity.miR-340 的恢复可控制胰腺癌细胞的表达,促进巨噬细胞吞噬作用,并增强抗肿瘤免疫。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000253.
2
An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.miR-340-5p-巨噬细胞反馈回路调控胶质母细胞瘤的进展和肿瘤微环境。
Oncogene. 2019 Dec;38(49):7399-7415. doi: 10.1038/s41388-019-0952-x. Epub 2019 Aug 19.
3
High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
糖尿病性心肌病中,非编码RNA与凋亡信号之间的相互调节回路。
Noncoding RNA Res. 2024 Jun 12;9(4):1080-1097. doi: 10.1016/j.ncrna.2024.06.011. eCollection 2024 Dec.
4
Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.定制 EV-CATCHER 从母体血浆中纯化胎盘细胞外囊泡以检测胎盘病理。
Int J Mol Sci. 2024 May 7;25(10):5102. doi: 10.3390/ijms25105102.
5
Topology and Dynamics of Transcriptome (Dys)Regulation.转录组(失调)调控的拓扑和动力学。
Int J Mol Sci. 2024 May 2;25(9):4971. doi: 10.3390/ijms25094971.
6
The Involvement of the microRNAs miR-466c and miR-340 in the Palmitate-Mediated Dysregulation of Gonadotropin-Releasing Hormone Gene Expression.微小RNA miR-466c和miR-340参与棕榈酸酯介导的促性腺激素释放激素基因表达失调
Genes (Basel). 2024 Mar 23;15(4):397. doi: 10.3390/genes15040397.
7
Drug resistance in ovarian cancer: from mechanism to clinical trial.卵巢癌的耐药性:从机制到临床试验。
Mol Cancer. 2024 Mar 28;23(1):66. doi: 10.1186/s12943-024-01967-3.
8
MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review.基于 microRNA 的联合治疗通过灭活 PI3K/Akt/mTOR 通路对抗 TKI 耐药 CML:综述。
Med Oncol. 2023 Sep 15;40(10):300. doi: 10.1007/s12032-023-02161-z.
9
A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids.一种小鼠系统遗传学方法揭示了肝脏溶酶体酶活性和糖鞘脂的常见和罕见遗传修饰因子。
Int J Mol Sci. 2023 Mar 3;24(5):4915. doi: 10.3390/ijms24054915.
10
Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women.循环 miR-340-5p 和 miR-506-3p 作为两种骨 miRNA 预测绝经后妇女骨质疏松症的队列研究。
J Environ Public Health. 2023 Jan 31;2023:7571696. doi: 10.1155/2023/7571696. eCollection 2023.
长链非编码 RNA LINC00662 高表达通过海绵吸附 microRNA-340-5p 上调 ROCK1 促进急性髓系白血病细胞的恶性生长。
Eur J Pharmacol. 2019 Sep 15;859:172535. doi: 10.1016/j.ejphar.2019.172535. Epub 2019 Jul 12.
4
miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.miR-340-5p通过靶向Bcl-w和Sox2抑制多形性胶质母细胞瘤的侵袭性。
Mol Ther Nucleic Acids. 2019 Sep 6;17:245-255. doi: 10.1016/j.omtn.2019.05.022. Epub 2019 Jun 5.
5
LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.长链非编码 RNA HAND2-AS1 通过作为 microRNA-340-5p 的海绵恢复 BCL2L11 发挥抑癌作用对卵巢癌。
J Cell Physiol. 2019 Dec;234(12):23421-23436. doi: 10.1002/jcp.28911. Epub 2019 Jun 21.
6
MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503.microRNA-340-5p 通过靶向 ZNF503 抑制非小细胞肺癌细胞的生长和转移。
Cell Mol Biol Lett. 2019 May 28;24:34. doi: 10.1186/s11658-019-0161-1. eCollection 2019.
7
WITHDRAWN: MicroRNA-340 suppresses pancreatic cancer growth by targeting BICD2.撤回:微小RNA-340通过靶向BICD2抑制胰腺癌生长。
Pancreatology. 2019 May 9. doi: 10.1016/j.pan.2019.05.453.
8
miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.miR-340-FHL2 轴抑制卵巢癌细胞生长和转移。
Cell Death Dis. 2019 May 8;10(5):372. doi: 10.1038/s41419-019-1604-3.
9
Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.多发性骨髓瘤中 miR-340-5p 的表观遗传沉默:机制和预后影响。
Clin Epigenetics. 2019 May 7;11(1):71. doi: 10.1186/s13148-019-0669-2.
10
Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.靶向 SPP1 的 microRNA-340 通过抑制 PI3K/AKT 信号通路抑制胃癌细胞上皮-间充质转化。
J Cell Physiol. 2019 Aug;234(10):18587-18601. doi: 10.1002/jcp.28497. Epub 2019 Apr 5.